S3 Investments - 500 Beiträge pro Seite

[Nukem]

S3 Investment Company CEO Discusses $800,000 Quarterly Revenue Number for SINO UJE Subsidiary
S3 Investment Company Inc. (OTCBB:SEIH) Chairman and Chief Executive Officer Chris Bickel today has issued a statement discussing the financial performance of portfolio investment SINO UJE Ltd. during the most recent completed quarter.

"The fiscal quarter referenced in these numbers ended almost two months ago, but we feel that it is important to provide shareholders with as much information as possible on our operating subsidiaries, and how they are now positioned to provide return for S3 shareholders," commented Chris Bickel, chairman and chief executive officer of S3 Investment Company.

During the second calendar quarter of 2005, SINO UJE reported gross revenues of over $800,000 (USD) with a net profit of approximately $133,000. Over the same period in 2004, SINO achieved just under $200,000 in revenues.

By the middle of 2005, SINO had reached the $1 million mark in gross revenue for the year and was on pace to exceed the projections made for this portfolio investment at the beginning of 2005.

"The capital provided by S3 since its acquisition of SINO UJE has made it possible for the company to expand its business and significantly improve its performance over the same period last year. SINO has achieved profitability and is expected to continue growing its top and bottom line numbers. We anticipate that SINO`s ongoing expansion of sales to new market sectors will bring in even better results for the remaining quarters in calendar year 2005," added Mr. Bickel.

Detailed financial information on the SINO UJE portfolio investment will be included in the company`s upcoming 10-K Annual Report, scheduled for September.

SINO UJE is in the business of distributing high-tech medical and industrial products to markets throughout China. The company purchases products from Original Equipment Manufacturers (OEMs) in North America, Europe and Japan and resells the equipment to end users through its distribution network in China. The revenue numbers represent sales in the Medical and Industrial divisions of the business and S3 Investments is projecting continued growth throughout the year as its expansion program for SINO UJE is executed.

About the Company

S3 Investment Company Inc. (http://www.s3investments.com) is a Business Development Company regulated by the Investment Company Act of 1940. Its first operating subsidiary, Securesoft Systems Inc. (http://www.securesoftsystems.com), was acquired in April 2003. S3 Investments has subsequently acquired 100 percent of Redwood Capital (http://www.redwoodcapinc.com) to participate in the fast-growing investment banking market in China and 51 percent of SINO UJE (http://www.sinouje.com), a non-stocking distributor of medical and industrial high-tech products to markets throughout China. S3 is currently seeking to acquire additional synergistic companies and is focused on assembling a portfolio of investments that will provide value to its shareholders.

Any statements contained herein related to future events are forward-looking statements and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on forward-looking statements. S3 Investment Company Inc. undertakes no obligation to update any such statements to reflect actual events.


Gemini Financial Communications for S3 Investment Co.
A. Beyer, 951-587-8072
[e-mail]



Source: Business Wire (August 18, 2005 - 12:10 PM EDT)

News by QuoteMedia
www.quotemedia.com

[Nukem]

Wer kennt den Titel? Hört sich mal nicht schlecht an, oder?

[Nukem]

Der CEO Chris Bickel hatte erst vor zwei Wochen, am 11. August 2005 wieder eigene Aktien von seiner S3 Investment Company WKN 814 057 gekauft.

Zwei S3 Unternehmung SINO UJE und Redwood erzielten beachtlich Umsatzwachstum, so das der CEO schon jetzt sagt, die für 2006 gesteckten Ziele übertreffen zu können.

[Nukem]

Nach dem positiven Geschäftsverlauf bringt der CEO am 16.08.2005 in einer Unternehmensverlautbarung, einen Rückkauf eigener Aktien ins Gespräch. Bickel ist der Meinung, dass Aktien unterbewertet seien.

[Nukem]

Der Titel wird ja in Fra, Berlin und sogar im Xetra gehandelt. In Frankfurt liegen gerade mal 150 000 Stücke drinnen. In Berlin 1 000 000 und xetra nichts. Berlin scheint am Umsatzstärksten zu sein.

Nach welchen Kriterien entscheidet sich die Zulassung an dieses deutschen Börsenplätzen? Ein einfacher Antrag wird hierfür nicht genügen, oder?